We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$529M
AUM Growth
-$8.78M
Cap. Flow
+$69.8M
Cap. Flow %
13.2%
Top 10 Hldgs %
43.59%
Holding
74
New
3
Increased
38
Reduced
19
Closed
4

Top Buys

Rank Stock Value
1
GWW icon
W.W. Grainger
GWW
+$7.37M
2
JNJ icon
Johnson & Johnson
JNJ
+$7.24M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.37M
4
SNY icon
Sanofi
SNY
+$5.33M
5
MDT icon
Medtronic
MDT
+$4.8M

Top Sells

Rank Stock Value
1
ANF icon
Abercrombie & Fitch
ANF
+$8.59M
2
TDW icon
Tidewater
TDW
+$5.52M
3
HWC icon
Hancock Whitney
HWC
+$4.41M
4
CAG icon
Conagra Brands
CAG
+$4.28M
5
SEM
Select Medical
SEM
+$3.92M

Sector Composition

Rank Sector Weight
1 Healthcare 33.01%
2 Financials 13.9%
3 Technology 12.16%
4 Industrials 10.24%
5 Materials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$42.4B
$37.4M 7.06%
569,245
+103,030
+22% +$6.37M
MDT icon
2
Medtronic
MDT
$120B
$35.3M 6.68%
459,544
+63,742
+16% +$4.8M
VZ icon
3
Verizon
VZ
$208B
$22.9M 4.32%
495,011
+72,094
+17% +$3.27M
JNJ icon
4
Johnson & Johnson
JNJ
$663B
$22.8M 4.3%
221,651
+71,967
+48% +$7.24M
MSFT icon
5
Microsoft
MSFT
$3.71T
$22.6M 4.28%
408,069
-20,698
-5% -$1.09M
PNC icon
6
PNC Financial Services
PNC
$98B
$20.4M 3.87%
214,545
+7,619
+4% +$708K
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
$19.3M 3.64%
226,263
+37,920
+20% +$3.22M
MET icon
8
MetLife
MET
$62B
$18.9M 3.56%
438,938
+81,518
+23% +$3.58M
MAT icon
9
Mattel
MAT
$4.15B
$15.6M 2.95%
573,872
-41,300
-7% -$1.02M
PFE icon
10
Pfizer
PFE
$162B
$15.4M 2.92%
503,923
+51,836
+11% +$1.63M
JCI icon
11
Johnson Controls International
JCI
$87.8B
$15M 2.83%
362,203
+73,489
+25% +$3.32M
AVT icon
12
Avnet
AVT
$7.56B
$14.6M 2.76%
340,590
+51,351
+18% +$2.31M
BG icon
13
Bunge Global
BG
$22.8B
$13.9M 2.62%
202,860
+44,972
+28% +$3.17M
BAX icon
14
Baxter International
BAX
$13.4B
$13.1M 2.47%
342,647
+37,590
+12% +$1.37M
STT icon
15
State Street
STT
$53.4B
$12.9M 2.44%
194,351
+37,283
+24% +$2.59M
TUP
16
DELISTED
Tupperware Brands Corporation
TUP
$12.3M 2.33%
221,700
+52,846
+31% +$2.97M
CHKP icon
17
Check Point Software Technologies
CHKP
$14B
$11.7M 2.22%
144,273
+29,099
+25% +$2.41M
PPL
18
PPL Corp
PPL
$26.4B
$10.8M 2.05%
317,871
+26,798
+9% +$904K
MOS icon
19
The Mosaic Company
MOS
$8.22B
$9.7M 1.83%
351,507
+57,134
+19% +$1.82M
ORCL icon
20
Oracle
ORCL
$457B
$9.25M 1.75%
253,165
+55,979
+28% +$2.14M
UNP icon
21
Union Pacific
UNP
$172B
$9.2M 1.74%
117,620
+18,620
+19% +$1.6M
APA icon
22
APA Corp
APA
$15B
$9.06M 1.71%
203,714
+52,379
+35% +$2.44M
RGA icon
23
Reinsurance Group of America
RGA
$16.5B
$9.01M 1.7%
105,280
+31,458
+43% +$2.85M
EMR icon
24
Emerson Electric
EMR
$85.2B
$8.72M 1.65%
182,357
+52,931
+41% +$2.52M
ICL icon
25
ICL Group
ICL
$7.58B
$8.63M 1.63%
2,130,982
+757,106
+55% +$3.8M

Similar funds

Foyston, Gordon, & Payne's Q4 2015 Portfolio in Review

As of Q4 2015, Foyston, Gordon, & Payne held 74 positions worth $529M, down 1.6% from $538M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Foyston, Gordon, & Payne deployed $69.8M of net new capital in Q4 2015, opening 3 new positions and adding to 38 existing holdings. Its largest new stake was W.W. Grainger: 35,875 shares worth $7.27M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Conagra Brands, an estimated $4.28M trimmed.

  • Foyston, Gordon, & Payne's largest Q4 2015 buy was W.W. Grainger: 35,875 shares worth $7.27M.
  • Foyston, Gordon, & Payne added most to Johnson & Johnson in Q4 2015, an estimated $7.24M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2015 reduction was Conagra Brands, cutting an estimated $4.28M.
  • Foyston, Gordon, & Payne fully exited Abercrombie & Fitch in Q4 2015, selling an estimated $8.59M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 44% of its $529M portfolio in Q4 2015.
  • Foyston, Gordon, & Payne opened 3 new positions and closed 4 in Q4 2015.
  • Foyston, Gordon, & Payne's portfolio value fell 1.6% quarter-over-quarter to $529M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2015, filed 12 Feb 2016.